Ip Share Discussion Threads

[masurenguy] 08/12/2020 08:15

"Assuming we are entering a new trading range starting at 85, the upper end should be around 93-94."

Well bamboo2, we're there this morning. Will it break through to the upside or will it become a new resistance level!

[bamboo2] 05/12/2020 09:14

Hi Wp, Yes I think you are right. There will come a point where selling pressure is lowered.

It'll be interesting to see over the next few weeks if price stays in the trading range, as it has done before. I listed these ranges in a previous post. If it matches those previously, the current one ends around 13/1/2021, and price should move to a new range then.

=============================================
From 18/11/2020

Based on previous consolidation zones, the stock was due a rerate to a higher trading range.

Each zone is 41-42 sessions long.

Since the uptrend began the ranges are 11, 9.6, 7.6, 8.1

Assuming we are entering a new trading range starting at 85, the upper end should be around 93-94.
============================================

gla

[wetpantz] 05/12/2020 02:09

BB, I did similar with AAF which has worked well but I reckon there's more sticky money coming into the market now so there may be less volatility on the way up.

[bamboo2] 04/12/2020 16:49

Wetpantz, I attempting to trade the uptrend and am planning to buy back in as soon as possible. My holding fluctuates from 10-80k, and I normally average in and out in 10-20k lots.

This has ben a superb share to trade this year. I must have done 100's of trades. My broker and the stamp duty collector have also done very well! :-)

[wetpantz] 04/12/2020 16:32

I'm still holding on (25% of portfolio). Now that invesco and lansdowne largely sold out overhang is gone and the trend up since April has been v consistent. Short sellers got out ages ago and IPO seems to have left the Woodford debacle well and truly in the past. Will only consider selling once NANOPORE goes public.

[bamboo2] 04/12/2020 14:50

p1nk, thanks. No worries.

Lansdowne below 5% from 1/12/2020

Have sold most of mine for now on the rise to 94 as think this is near the top of the current trading range. Hope I can buy back a bot lower down, rather than have to chase up!

gla

[p1nkfish] 03/12/2020 21:38

bamboo, I don 't remember their routines for notifying on 2%+ holders.

[bamboo2] 03/12/2020 20:23

Good vibrations as 8powerUK raises £2m growth capital to underpin expansion across the UK and Europe. The round includes follow-on investment from IPGroupplc...



ABOUT 8POWER
8power is a Cambridge, UK based innovative technology company specialising in self-powered wireless sensor solutions for industrial plant applications. We are enabling machine condition monitoring at lower cost and easy installation for water/waste treatment, manufacturing industries and oil and gas industries. The 8power solution is based on ground breaking, patented technology from the University of Cambridge.

8POWER SOLUTION
8power’s technology provides a proactive, early warning and remote monitoring solution for a range of industrial plant equipment. This offers organisations a self-powered, scalable solution to monitor plant equipment installed in unmanned, remote or difficult to reach locations. 8power uses energy harvested from the assets environment to provide an easy to install, efficient and consistent way of monitoring different sizes and types of industrial asset.

VIBRATION ENERGY HARVESTING
Our patented Vibration Energy Harvester (VEH) technology provides self-powered wireless sensors that eliminate battery changes or wiring of power supplies. This dramatically lowers the cost of installation and operation over the life of an asset. VEH provides a sustainable and scalable solution to address the sensing needs of a range of equipment types.

[bamboo2] 03/12/2020 20:09

B/f, have a look at the last report to get more detail on the overheads and staff numbers. Some of the smaller companies have their employees and overheads lumped in with IPO's.

Page 23 of the IP Group half year report

Included within the Group’s administrative
expenses are costs in respect of a small number
of other portfolio companies. Typically, the Group
owns a non-controlling interest in its portfolio
companies; however, in certain circumstances
the Group takes a controlling stake and hence
consolidates the results of a portfolio company
into the Group’s financial statements. The
administrative expenses included in the Group’s
results for such companies primarily comprise
staff costs, R&D and other operating expenses.
These costs included consolidated costs in
respect of MOBILion Systems, Inc., for the first
half of 2019 until its deconsolidation on 1 July
2019

[bamboo2] 03/12/2020 17:06

p1nkfish, you've been holding here for quite a while, so I thought you would be a good person to ask.

I have had quite a few emails with the co, and on a recent reply about rns holdings notices was told that there would be an end of year report for 2020 with an update on holders above 2%.

Do you know, is this normally released at the end of December, or do we have to wait until March 2021 for the report, along with the final results?

[p1nkfish] 03/12/2020 15:39

Draper tend to hold stuff that will surprise but not totally left field. Evolution, Graphcore.

IPO has the real surprise potential where something comes along as another Ox Nano but in fusion or some other area.

[p1nkfish] 03/12/2020 15:38

B/f, I hold both and not a bad idea to do so. Fundamental science out of Uni with long term focus - IPO sort of field.

EU focused digital and disruptive in short/med term is Draper.

Not a lot of overlap. Both have a reason to be held.
I also hold some MERC for the regional exposure up north.
A sucker for start-ups.

[bamboo2] 03/12/2020 15:29

B/f With the death of Woodford last year, IPGroup was in a situation where nearly 50% of the company was in the hands of forced sellers. That is why these shares were under 50p at one point.

Additional downward valuation pressure was caused by crossholdings of IPgroups listed and unlisted p/f constituents by WIM, Invesco, and Lansdowne.

This situation has been managed really well imo, and the worst looks to be behind us now. WIM is out of it. Invesco are below 10%. Lansdowne are closing one of their funds, and we are still waiting to find out what the plans are with the approx 9% they hold.

At the end of the year there is a report that should give us all more clarity.

[bottomfisher] 03/12/2020 15:09

Today's Artois announcement suggests there might be more value hidden in the lower reaches of IPO's portfolio than the market suspects. However, even after the recent rally, the IPO share price is still trading at a 17% discount to NAV, whilst Draper Esprit (GROW), a fast growing VC rival, trades at a 9% premium and seems to have no difficulty regularly placing £100m plus tranches of shares priced at close to NAV to fund its portfolio of high growth disruptive tech stocks. Interested in any thoughts on which vehicle might make the better long-term investment. Am tempted to go for Draper Esprit but worried that one day IPO will finally surprise its long suffering shareholders on the upside.

[bamboo2] 03/12/2020 09:17

There are some real gems in the p/f. It's worth a dig around on the co. website.

Linked to Artois, Oxford Nanopore's [ONT] Twitter is well worth following, even if some of the tech is a bit much at times. Their market is rapidly broadening.

Some of the listed flatliners in post one are stirring.
DNL, MIRI, and TRX have all caught my eye.

rambutan, I had a reply from Invesco, but they are not able to discuss with non account holders. I won't follow up, as you say, they are normally good at providing holdings rns.

Obvious now there is a large buyer/s in the background.

PS. Ip Group Plc hit an upwards yearly price breakout this morning.

[p1nkfish] 03/12/2020 08:55

Very useful arrangement and uplift in value immediate, could be substantial if proceeds well.

[benchmark] 03/12/2020 08:27

Bamboo - thanks for that

[bamboo2] 03/12/2020 08:07

IP Group plc - Portfolio company Artios and Merck KGaA, Darmstadt, Germany announce a global strategic collaboration on novel DNA Damage Response targets in oncology

-- Artios to receive US$30m in upfront and near-term payments and up to US$860m total milestones per target

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, is delighted to note that portfolio company Artios Pharma Ltd ("Artios"), a leading DNA Damage Response (DDR) company focused on developing a broad pipeline of precision medicines for the treatment of cancer, and Merck KGaA, Darmstadt, Germany ("Merck"), a leading science and technology company, have announced a global three-year strategic research collaboration to discover and develop multiple precision oncology drugs.

As part of the agreement, Artios will receive a payment of US$30m in the form of up-front and near-term payments. If Merck chooses to exercise the option, subject to double digit option fees, Artios will be eligible to receive up to US$860m per target , in addition to up to double digit royalty payments on net sales of each product commercialised by Merck. Subject to certain conditions, Artios has opt-in rights for joint development and commercialization with Merck for the programmes.

IP Group has an 11.7% undiluted beneficial holding in Artios that was valued at GBP11.0m as at 30 June 2020. The directors anticipate that the Group's assessment of the value of its holding in Artios may increase by GBP5m-GBP15m as a result of the collaboration and will finalise this during the Group's 2020 Annual Results valuation process.

Under the terms of the agreement, the companies will leverage Artios's proprietary nuclease targeting discovery platform to jointly identify multiple synthetic lethal targets for precision oncology drug candidates. During this joint research collaboration, Merck will contribute its significant expertise and resources in the field of DDR and will have options to licence up to eight nuclease targets with exclusive worldwide rights to develop and commercialize select therapeutics discovered under the collaboration. The collaboration does not include Artios' lead programmes, Pol and ATR inhibitors, for which Artios will retain all rights.

[bamboo2] 01/12/2020 09:18

The new trading range started on 17/11/2020 and is now 11 sessions long.

The lower level is approx 85. Upper level is currently 92.2, but I forecast that based on the previous ranges, that the upper level could rise to approx 94.

[bamboo2] 01/12/2020 08:35

Benchmark, thank you for the post. I have a basic understanding of the UT, but always good to refresh.

One fact I am aware of is that the UT, which is often a slightly different price to the last trade, is also the opening price for the following session. This can sometimes explain the gap up or down that occurs at the start of the following session.

It was the size of the UT that was comment worthy last night.

[benchmark] 01/12/2020 08:23

Bamboo - to understand what UT type trades are this might help
hxxp://www.traderslaboratory.com/forums/topic/9228-uncrossing-trade/

[p1nkfish] 30/11/2020 20:57

So much for rules and regs on holding announcements.

[bamboo2] 30/11/2020 20:02

8m more at 85.991 timed at 18:45

That's 4% or so of the co traded today.

There's approx 180m in larger trades unaccounted for on the buy side since Sept 2020! ie we have no buyers rns to confirm a new, or increased position.

Maybe 15-20%?

[bamboo2] 30/11/2020 16:41

Another 28,000,000 or so as the UT at 86

I bought a few more today, but not that many!